REQUEST A DEMO
Total
USD $0.00
Search more companies

Fast Pharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Fast Pharma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fast Pharma Sas is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 23, 2016. There are currently 6 (2024) people employed by Fast Pharma Sas. The company’s latest financial report indicates a net sales revenue increase of 37.91% in 2023. During that time, Fast Pharma Sas’s total assets grew by 12.11%. In 2023, Fast Pharma Sas’s net profit margin decreased by 1.43%.

Headquarters
Ca 127 16 A 76 Of 401
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Fast Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Fast Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Fast Pharma Sas report to view the information.
Incorporation Date:
February 23, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Fast Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
37.91%
Total operating revenue
37.91%
Operating profit (EBIT)
374.69%
Net Profit (Loss) for the Period
-37.09%
Total assets
12.11%
Total equity
2.84%
Operating Profit Margin (ROS)
4.07%
Net Profit Margin
-1.43%
Return on Equity (ROE)
-2.97%
Quick Ratio
-0.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?